DCM-KPV
DCM-KPV is a fluorescent probe targeting the human intestinal oligopeptide transporter PEPT1/SLC15A1 receptor (λex=480 nm, λem=620-670 nm). DCM-KPV specifically binds to PepT1 via its KPV domain and mediates receptor-targeted internalization, thus effectively accumulating in the cytoplasm and nucleus of cells overexpressing this receptor. DCM-KPV has the advantages of long emission wavelength, high emission efficiency, low photobleaching, and negligible cytotoxicity. DCM-KPV maintains stable fluorescence intensity under continuous illumination, exhibiting extremely high live cell compatibility. DCM-KPV can specifically accumulate at colonic inflammatory sites through the intestinal mucosa, enabling direct non-invasive visual differentiation between chronic and acute ulcerative colitis groups and the normal group.
For research use only. We do not sell to patients.
- CAS No.: 2098632-04-1
- Formula: C40H48N8O4
- Molecular Weight:704.86
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
DCM-KPV (1-30 μM; 24-72 h) exhibits negligible cytotoxicity and high cytocompatibility with Caco-2 cells[2].
DCM-KPV (1.0 μM; 50 min) is efficiently internalized into Caco-2 cells via PepT1 receptor-mediated uptake, accumulating in the cytoplasm and nucleus[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:PepT1-overexpressed Caco-2 human colon adenocarcinoma cells
-
Concentration:1-30 μM (viability assays); 1-30 μM (apoptosis assays)
-
Incubation Time:24-72 h (viability assays); 24 h (apoptosis assays)
-
Result:Maintained >95% cell viability at all tested concentrations and incubation times.
Showed no significant differences in cell proliferation rate or cell growth inhibition rate relative to controls after 24, 48, and 72 h of incubation.
Showed no appreciable increase in apoptosis rate relative to controls after 24 h of incubation.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c mice with Ulcerative colitis (male, 6-8-week-old)[2]
-
Dosage:2.5 mg/kg
-
Administration:via anus; single dose; reserved for 1 hour
-
Result:Reached an average fluorescence intensity of 9.33E+08 a.u. in distal colon tissues of chronic colitis mice.
Reached an average fluorescence intensity of 4.08E+08 a.u. in distal colon tissues of acute colitis mice.
Reached an average fluorescence intensity of 2.25E+08 a.u. in distal colon tissues of normal control mice.
Chemical Information
-
CAS No. 2098632-04-1
-
Molecular Weight 704.86
-
Formula C40H48N8O4
-
SMILES
N#C/C(C#N)=C1C2=CC=CC=C2OC(/C=C/C3=CC=C(N4CCN(CC4)C([C@H](C(C)C)NC([C@H]5N(CCC5)C([C@@H](N)CCCCN)=O)=O)=O)C=C3)=C\1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
DSS-Induced Colitis
Dextran sulfate sodium (DSS)-induced colitis is generated by administering DSS in mouse drinking water, producing epithelial injury, barrier disruption, weight loss, diarrhea, fecal blood, colon shortening, histologic mucosal damage, and inflammatory mediator changes; the model is mainly used to study acute or chronic intestinal inflammation resembling selected features of ulcerative colitis. DSS injury is interpreted through clinical and tissue readouts rather than a single molecular endpoint: daily body weight, stool consistency, and bleeding are combined into a disease activity index, while colon length, histology, cytokines, myeloperoxidase activity, intestinal permeability, and tight-junction markers provide complementary measures of inflammation and barrier damage.
-
TNBS-Induced Colitis
TNBS-induced colitis is produced by intrarectal delivery of 2,4,6-trinitrobenzene sulfonic acid in ethanol, where ethanol disrupts the mucosal barrier and TNBS haptenates colonic proteins, generating immune-mediated colonic inflammation with weight loss, diarrhea, ulceration, transmural injury, inflammatory-cell infiltration, and cytokine responses. The model is used as an experimental intestinal inflammation model with Crohn’s disease–like features, especially when Th1-type responses, IL-12–dependent inflammation, chronic relapsing inflammation, or fibrosis-related endpoints are studied.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)